
Will regulatory and financial considerations dampen innovation in the clinical microbiology laboratory?
Author(s) -
Peter H. Gilligan,
Melissa B. Miller
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/cqdh-1p64
Subject(s) - clinical microbiology , business , accounting , microbiology and biotechnology , biology